ClassID:

113810

C12Y104/03004 - CPC Classification

Classification description:

Oxidoreductases acting on the CH-NH2 group of donors (1.4) with oxygen as acceptor (1.4.3) Monoamine oxidase (1.4.3.4)

Recent Application in this class:
#1
20260139105
2026-05-21

Collagen Hydrogel, Preparation Method Therefor, and Use Thereof

#2
20250366499
2025-12-04

Flavin-Containing Monoamine Oxidase MAO6sh Capable of Degrading Biogenic Amines and Application Thereof

#3
20250340884
2025-11-06

ANTISENSE OLIGOMERS AGAINST MONOAMINE OXIDASE B AND USE THEREOF

#4
20250207108
2025-06-26

MONOAMINE OXIDASE AND APPLICATION THEREOF

#5
20240263204
2024-08-08

METHOD FOR PREPARING S-NICOTINE

#6
20240076711
2024-03-07

IDENTIFICATION OF MITOCHONDRIA-ENRICHED CELLS

#7
20240043884
2024-02-08

RECOMBINANT ESCHERICHIA COLI FOR PRODUCING GLUTARATE, CONSTRUCTION METHOD AND USE THEREOF

#8
20230340036
2023-10-26

HETEROLOGOUS PROTEINS WITH AXONEMAL PROTEINS

#9
20230287361
2023-09-14

ENGINEERED MONOAMINE OXIDASES FOR THE PREPARATION OF STEREOMERICALLY PURE FUSED BICYCLIC PROLINE COMPOUNDS

#10
20210087595
2021-03-25

Method for preparing (S)-1-benzyl-1,2,3,4,5,6,7,8-octahydroisoquinoline compound

#11
20200181077
2020-06-11

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

#12
20200165552
2020-05-28

Methods to improve beverage quality

#13
20180360843
2018-12-20

MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer

#14
20180177786
2018-06-28

MONOAMINE OXIDASE INHIBITORS AND METHODS FOR TREATMENT AND DIAGNOSIS OF PROSTATE CANCER

#15
20180153839
2018-06-07

Compositions and methods to reduce pharmaceutical-induced toxicity

#16
20170226559
2017-08-10

Markers for mood disorders

#17
20170158633
2017-06-08

Cyclopropylamines as LSD1 inhibitors

#18
20170029371
2017-02-02

MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer

#19
20160355823
2016-12-08

Control of Varroa mite infestation

#20
20160339034
2016-11-24

MAO inhibitors and their conjugates as therapeutics for the treatment of brain cancer

#21
20150225375
2015-08-13

Cyclopropylamines as LSD1 inhibitors

#22
20130039854
2013-02-14

Monoamine oxidase inhibitors and methods for treatment and diagnosis of prostate cancer

#23
20120289709
2012-11-15

Substantially Stereomerically Pure Fused Bicyclic Proline Compounds and Processes for Preparing Boceprevir

#24
20120244581
2012-09-27

Biocatalytic processes for the preparation of stereomerically pure fused bicyclic proline compounds

#25
20120130087
2012-05-24

Stereomerically pure fused bicyclic proline compounds useful for preparing hepatitis C protease inhibitors

#26
20120108500
2012-05-03

Compositions and Methods for Modulating Immunodeficiency Virus Transcription

#27
20100136651
2010-06-03

Detection, isolation and uses of renalase (monoamine oxidase C)

#28
20100063300
2010-03-11

Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds

#29
20080003209
2008-01-03

Method for treatment of neurodegenerative diseases and the effects of aging

#30
20070275083
2007-11-29

Detection, isolation and uses of renalase (monoamine oxidase c)